QQ客服 官方微博 反馈留言

	Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer
	Lin, Mao[1,2]; Liang, Shuzhen[1]; Wang, Xiaohua[1]; Liang, Yinqing[1]; Zhang, Mingjie[4]; Chen, Jibing[1,2]; Niu, Lizhi[1,2,3]; Xu, Kecheng[1,2]
	2017
卷号	186期号:[db:dc_citation_issue]页码:20
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3361392
专题	暨南大学
作者单位	1.[1]Jinan Univ, Sch Med, Fuda Canc Hosp, Dept Biol Treatment Ctr, Guangzhou, Guangdong, Peoples R China 2.[2]Fuda Canc Inst, Guangzhou, Guangdong, Peoples R China 3.[3]Jinan Univ, Sch Med, Fuda Canc Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China 4.[4]Hank Bioengn Co Ltd, Shenzhen, Peoples R China
推荐引用方式 GB/T 7714	Lin, Mao[1,2],Liang, Shuzhen[1],Wang, Xiaohua[1],et al. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer[J],2017,186([db:dc_citation_issue]):20.
APA	Lin, Mao[1,2].,Liang, Shuzhen[1].,Wang, Xiaohua[1].,Liang, Yinqing[1].,Zhang, Mingjie[4].,...&Xu, Kecheng[1,2].(2017).Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.,186([db:dc_citation_issue]),20.
MLA	Lin, Mao[1,2],et al."Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer".186.[db:dc_citation_issue](2017):20.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。